Tagged with Franc

Colombia The Top 10 pharma companies in the Colombian pharma market ranked by operating income for the year 2020. Local players Droguerías y Farmacias Cruz Verde, Audifarma, Copidrogas, Tecnoquimicas, and Copservir make up the top five spots. German giant Bayer in sixth position is the highest placed multinational. Made with Visme…

Europe The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take top spot. This data is taken from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma industry.   Switzerland Despite boasting a population just one…

Europe The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest and most developed nations are represented, other smaller countries are punching above their weight. This data is taken from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma…

Europe Drawing from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma industry, we present the Top 5 countries across a variety of pharma metrics: from market size to R&D spend, production, exports, imports, and generics penetration.   Made with Visme Infographic Maker   Made with…

France Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director David Lescuyer charts the fully integrated French CDMO’s startling growth trajectory over the past five years and outlines how the firm is well positioned for further growth. Lescuyer also highlights some of the key…

France The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical production back to Europe has hit a wall, Sanofi’s slow progress towards finally bringing its COVID-19 vaccine candidate to market, and why investors are still betting on Valneva.   Macron’s Push for German Pharma Alliance…

France The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and Servier lead the way, followed by Bayer, Janssen and Mylan. French firms Pierre Fabre, Merial and Ceva Sante also make the list, while AstraZeneca and Teva round out the Top 10.…

France While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for their work on COVID-19 vaccines, smaller and  lesser-known companies are also playing a crucial role in the development of both large companies’ candidates and their own self-developed shots.   At the onset…

China Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the company’s unique single-cell technology platform, its open innovation approach, experience with capital markets, and advice for other biotech leaders.   The traditional bulk analysis method is well-established and suited for diseases that are more homogenous, but cancer…

France The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its in-house product and the impact of this on the country’s global scientific standing. Also featured are the rising problem of anti-vaccine sentiment, an exclusive…

Global In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the iconic French mid-cap; its EUR 3 billion war chest for bolt-on acquisitions; planned expansions in rare- and ultra-rare diseases; and the niche oncology segments where…

France A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how Ipsen has managed to achieve sales growth in 2020 despite the pandemic, diagnostics biotech Novacyt’s remarkable rise, and a new job for former Ipsen boss Marc de Garidel.   Sanofi aims for COVID-19…